chr3-47121171-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_014159.7(SETD2):c.3465T>C(p.Asn1155Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.613 in 1,613,356 control chromosomes in the GnomAD database, including 305,165 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 32842 hom., cov: 32)
Exomes 𝑓: 0.61 ( 272323 hom. )
Consequence
SETD2
NM_014159.7 synonymous
NM_014159.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0840
Publications
37 publications found
Genes affected
SETD2 (HGNC:18420): (SET domain containing 2, histone lysine methyltransferase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
SETD2 Gene-Disease associations (from GenCC):
- Luscan-Lumish syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowthInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Rabin-Pappas syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndromeInheritance: AD Classification: STRONG Submitted by: ClinGen
- Sotos syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual developmental disorder, autosomal dominant 70Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 3-47121171-A-G is Benign according to our data. Variant chr3-47121171-A-G is described in ClinVar as [Benign]. Clinvar id is 586533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.084 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.653 AC: 99148AN: 151886Hom.: 32781 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
99148
AN:
151886
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.638 AC: 159998AN: 250966 AF XY: 0.626 show subpopulations
GnomAD2 exomes
AF:
AC:
159998
AN:
250966
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.608 AC: 888970AN: 1461350Hom.: 272323 Cov.: 44 AF XY: 0.606 AC XY: 440308AN XY: 726996 show subpopulations
GnomAD4 exome
AF:
AC:
888970
AN:
1461350
Hom.:
Cov.:
44
AF XY:
AC XY:
440308
AN XY:
726996
show subpopulations
African (AFR)
AF:
AC:
25407
AN:
33464
American (AMR)
AF:
AC:
33156
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
15413
AN:
26128
East Asian (EAS)
AF:
AC:
28044
AN:
39696
South Asian (SAS)
AF:
AC:
51357
AN:
86246
European-Finnish (FIN)
AF:
AC:
33403
AN:
53412
Middle Eastern (MID)
AF:
AC:
3064
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
662280
AN:
1111542
Other (OTH)
AF:
AC:
36846
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
19625
39250
58874
78499
98124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18170
36340
54510
72680
90850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.653 AC: 99271AN: 152006Hom.: 32842 Cov.: 32 AF XY: 0.651 AC XY: 48363AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
99271
AN:
152006
Hom.:
Cov.:
32
AF XY:
AC XY:
48363
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
31392
AN:
41448
American (AMR)
AF:
AC:
10161
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2055
AN:
3466
East Asian (EAS)
AF:
AC:
3548
AN:
5178
South Asian (SAS)
AF:
AC:
2909
AN:
4816
European-Finnish (FIN)
AF:
AC:
6650
AN:
10560
Middle Eastern (MID)
AF:
AC:
152
AN:
292
European-Non Finnish (NFE)
AF:
AC:
40692
AN:
67950
Other (OTH)
AF:
AC:
1330
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1734
3467
5201
6934
8668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2385
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Luscan-Lumish syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.